The findings were further supported by our in vivo PCA assay, an animal model for inflammatory reactions in Type I allergy, indicating that DCIR–/– mast cells had a significant reduction in IgE-mediated cutaneous anaphylaxis. The gene discussed is CLEC4A; the disease is allergic disease.